Bias and precision of measures of survival gain from right-censored data

Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT).

(2017) Daniel D. Von Hoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Simulating biologically plausible complex survival data

(2013) Michael J. Crowther et al.   STATISTICS IN MEDICINE

Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail

(2012) Qi Gong et al.   PHARMACEUTICAL STATISTICS

Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects

(2011) Ismail Jatoi et al.   JOURNAL OF CLINICAL ONCOLOGY

The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt

(2011) Patrick Royston et al.   STATISTICS IN MEDICINE

Area Between Curves: What You See Is Not What You Get

(2008) Mithat Gonen   JOURNAL OF CLINICAL ONCOLOGY